The Glp-1 Analog Liraglutide protects against angiotensin II and pressure overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling
Ipamorelin emerged from this programme as the first truly selective GHS-R1a agonist , a pentapeptide incorporating alpha-aminoisobutyric acid (Aib) at position 1, His at position 2, the unnatural D-2-naphthylalanine residue at position 3, D-Phe at position 4, and C-terminal Lys-NH2 and a structural solution that achieves high-affinity GHS-R1a binding and potent GH release while eliminating the receptor interactions responsible for prolactin and cortisol co-stimulation in non-selective first-generation GH secretagogues
On top of that, new indications, such as treating MASH or cardiovascular disease, could extend this exclusivity further, just like tirzepatides recent obesity approval will likely extend its control in that market
Alberta Drug Benefit: Special Authorization
Franx BAA, Arnoldussen IAC, Kiliaan AJ, Gustafson DR